Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC)

Authors

Tilak Patel, LSU Health Sciences Center - New OrleansFollow
Rachel Butz, LSU Health Sciences Center - New Orleans
Brian Boulmay, Division of Hematology and Oncology, Department of Medicine, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA 70112, USA.Follow
Vilija Vaitaitis, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

7-15-2025

Publication Title

Cancers

Abstract

Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine cutaneous malignancy with high rates of recurrence and metastasis. The treatment of MCC has historically involved surgery, radiation, and chemotherapy; however, current clinical trials are investigating immunotherapies, intratumoral injections, and combination therapies to improve outcomes. This review explores the current trends in clinical trials for MCC, highlighting recent advances in management.

PubMed ID

40723224

Volume

17

Issue

14

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Patel, Tilak; Butz, Rachel; Boulmay, Brian; and Vaitaitis, Vilija, "Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC)" (2025). School of Medicine Faculty Publications. 3994.
https://digitalscholar.lsuhsc.edu/som_facpubs/3994
10.3390/cancers17142340